<p>Fort Lee, NJ, Sept. 01, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company fo
<p>0500 US Eastern time, which is 0900 GMT:</p><ul><li>Remarks by ECB Board Member Luis de Guindos at an event organised by Foment del Treball (an employers' association)&
Leave a Comment